Evidence map›Paper›PMID 34818540›Full record

ArticleCell reports2021

Reprogramming of H3K9bhb at regulatory elements is a key feature of fasting in the small intestine.

Christopher J Terranova, Kristina M Stemler, Praveen Barrodia, Sabrina L Jeter-Jones, Zhongqi Ge, Marimar de la Cruz Bonilla, Ayush Raman, Chia-Wei Cheng, Kendra L Allton, Emre Arslan and 4 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Review
  3. Fasting primes small intestinal regeneration after damage via a microbiome-metabolite-chromatin axis.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Diet-induced chromatin states influence intestinal stem cell memory.bioRxiv : the preprint server for biology · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Dietary and metabolic effects on intestinal stem cells in health and disease.Nature reviews. Gastroenterology & hepatology · 2025
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Christopher J TerranovaDepartment of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Kristina M StemlerDepartment of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Praveen BarrodiaDepartment of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Sabrina L Jeter-JonesDepartment of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Zhongqi GeDepartment of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Marimar de la Cruz BonillaDepartment of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Ayush RamanDepartment of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Epigenomics Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Chia-Wei ChengKoch Institute for Integrative Cancer Research at MIT, Cambridge, MA 02139, USA.
Kendra L AlltonDepartment of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Emre ArslanDepartment of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Ömer H YilmazKoch Institute for Integrative Cancer Research at MIT, Cambridge, MA 02139, USA.
Michelle C BartonDepartment of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Kunal RaiDepartment of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: krai@mdanderson.org.
Helen Piwnica-WormsDepartment of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: hpiwnica-worms@mdanderson.org.
The University of Texas MD Anderson Cancer Center · USAllen Institute · USBroad Institute · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
Fasting Protects Small Intestinal Stem Cells from Lethal DNA Damage: Mechanistic Insight and Preclinical TranslationR01CA207236 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI PIWNICA-WORMS, HELEN M · 2017 to 2021
$2.4M
UCHL5 as a regulator and therapeutic target in metastatic melanomaR01CA245395 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI RAI, KUNAL · 2020 to 2024
$2.0M
Training Grant in Cancer BiologyT32CA186892 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI KALLURI, RAGHU · 2016 to 2020
$1.1M
Elucidating the role of fasting in intestinal stemness and tissue regenerationR00DK123407 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CHENG, CHIA-WEI · 2021 to 2023
$727k
Elucidating the Role of Fasting in GI Radioprotection: Applications in Pre-Clinical Pancreatic Cancer ModelF31CA210631 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DE LA CRUZ BONILLA, MARIMAR · 2017 to 2018
$58k
NCI NIH HHS F31 CA210631NCI NIH HHS P30 CA016672NCI NIH HHS R01 CA207236NCI NIH HHS R01 CA245395NCI NIH HHS T32 CA186892NIDDK NIH HHS R00 DK123407
6 · The paper itself

Abstract

β-hydroxybutyrate (β-OHB) is an essential metabolic energy source during fasting and functions as a chromatin regulator by lysine β-hydroxybutyrylation (Kbhb) modification of the core histones H3 and H4. We report that Kbhb on histone H3 (H3K9bhb) is enriched at proximal promoters of critical gene subsets associated with lipolytic and ketogenic metabolic pathways in small intestine (SI) crypts during fasting. Similar Kbhb enrichment is observed in Lgr5

Indexed as

3-Hydroxybutyric AcidAcetylationAnimalsChromatinFastingFemaleGene ExpressionGene Expression RegulationHistonesIntestine, SmallKetone BodiesLysineMaleMiceMice, Inbred C57BLPromoter Regions, Genetic3-Hydroxybutyric Acidbeta-lysineChromatinHistonesKetone BodiesLysinechromatin statesfasting responsegene expressionhistone modificationsketogenicsmall intestine cryptsβ-hydroxybutyrate

Identifiers

PMID34818540
PMCPMC8668154
OpenAlexW3217062327

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.